TrialJournal for immunotherapy of cancer2025

Cadonilimab combined with taxane and cisplatin as the first-line treatment of advanced esophageal squamous cell carcinoma: an open-label, multicenter phase II trial.

Wang Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.